Patient blood management & pre-operative anaemia optimisation
Patient blood management · Perioperative & Anaesthesia
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
A systematic strategy to optimise and conserve the patient's own blood across three pillars: detecting and treating anaemia, minimising blood loss, and harnessing physiological reserve to tolerate anaemia. Reduces allogeneic transfusion and improves outcomes.
Red flags
- Symptomatic anaemia (angina, breathlessness) before major surgery
- Haemoglobin <90 g/L undiagnosed before major elective surgery
- Occult GI malignancy suggested by new iron-deficiency anaemia
- Ongoing bleeding source not addressed before surgery
Assessment
Differential diagnosis
- Iron-deficiency anaemia (commonest, often from GI loss or menorrhagia)
- Anaemia of chronic disease/inflammation
- Functional iron deficiency with adequate stores
- B12/folate deficiency
- Renal anaemia (erythropoietin deficiency)
Investigations
- FBC with mean cell volume; aim to screen at least 4-6 weeks before major surgery
- Iron studies — ferritin and transferrin saturation (ferritin <30 microgram/L or TSAT <20% suggests deficiency)
- CRP to interpret ferritin in inflammation
- B12, folate, reticulocytes and renal function where indicated
- Group and save/crossmatch with maximum surgical blood ordering schedule
Management
- Screen for anaemia early in the elective pathway and investigate the cause before surgery
- Treat iron deficiency: oral iron if time allows, or intravenous iron when surgery is <6 weeks away or oral iron not tolerated/ineffective
- Correct B12/folate and treat renal anaemia (consider erythropoiesis-stimulating agents per protocol)
- Minimise iatrogenic blood loss and plan meticulous surgical/anaesthetic haemostasis
- Use antifibrinolytics and consider intraoperative cell salvage for high-loss surgery
- Apply restrictive transfusion thresholds and single-unit transfusion with reassessment
- Accept and support normovolaemic anaemia in fit patients rather than reflex transfusion
- Reassess haemoglobin postoperatively and continue iron replacement as needed
Drugs & doses
Oral iron — Ferrous sulfate 200 mg oral once daily (alternate-day dosing improves absorption)
Intravenous iron — Ferric carboxymaltose 1000 mg IV infusion when rapid correction needed
Antifibrinolytic — Tranexamic acid 1 g IV at induction (and per protocol) to reduce surgical bleeding
Transfusion threshold — packed red cells to target haemoglobin >70 g/L (>80 g/L if cardiac disease), single-unit then reassess
Disposition
Elective patients are optimised in a preassessment clinic before scheduling; anaemia identified late prompts deferral for iron therapy where surgical urgency allows.
Complications & pitfalls
- Avoidable allogeneic transfusion and its risks (reactions, immunomodulation, infection)
- Perioperative anaemia-related ischaemic events
- Cancellation/delay if anaemia found at last minute
- Missed GI malignancy if iron deficiency not investigated
Exam pearls
- New iron-deficiency anaemia in an adult mandates a GI source search — do not simply transfuse and operate
- Alternate-day oral iron dosing reduces hepcidin-mediated blockade and improves net absorption
- Preoperative anaemia is an independent predictor of morbidity, mortality and transfusion — treat it, do not transfuse through it
- Transfuse one unit then reassess; most stable patients tolerate restrictive thresholds
- IV iron is preferred when the surgical window is short or oral iron is ineffective
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.